Trust CO Of Toledo Na Viracta Therapeutics, Inc. Transaction History
Trust CO Of Toledo Na
- $636 Million
- Q1 2024
A detailed history of Trust CO Of Toledo Na transactions in Viracta Therapeutics, Inc. stock. As of the latest transaction made, Trust CO Of Toledo Na holds 12,317 shares of VIRX stock, worth $6,651. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,317
Previous 12,317
-0.0%
Holding current value
$6,651
Previous $7,000
71.43%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding VIRX
# of Institutions
43Shares Held
9.39MCall Options Held
5.9KPut Options Held
0-
Bvf Inc San Francisco, CA3.61MShares$1.95 Million0.11% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.57MShares$845,2090.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.16MShares$627,0910.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA690KShares$372,4420.22% of portfolio
-
Laurion Capital Management LP New York, NY420KShares$227,0300.0% of portfolio
About Viracta Therapeutics, Inc.
- Ticker VIRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,558,200
- Market Cap $20.3M
- Description
- Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...